Literature DB >> 30319942

MDMX under stress: the MDMX-MDM2 complex as stress signals hub.

Anna de Polo1, Varunika Vivekanandan1, John B Little1, Zhi-Min Yuan1.   

Abstract

The tumor suppressor p53 plays a central role in safeguarding cellular homeostasis. Upon various types of stress signals such as DNA damage or oncogenic stress, p53 is promptly activated to prevent and repair damages that can threaten the genome stability. The two major negative regulators of p53 are MDM2 and MDMX, two homolog proteins that control p53 activity and turnover, hence keeping it in check during normal cell cycling. In the event of cellular stress, they have to be inhibited in order to relieve p53 from their suppression and allow its activation. As the essential upstream modulator of p53, the MDMX-MDM2 complex integrates multiple signaling pathways regulating p53 response to perturbations of cellular homeostasis. Given its predominantly cytoplasmic localization in normal conditions, we hypothesize that MDMX, rather than MDM2, is the first recipient of signaling cues directed towards the MDMX-MDM2 complex and aimed at modulating p53. In this review we give a synthetic overview of the phosphorylation sites of MDMX that are known to affect its degradation, ubiquitination, intracellular localization and interaction with MDM2 and p53, ultimately modulating the stability and activity of p53. The role of MDMX in response to the main types of cellular stress is also briefly discussed, along with the potential of the MDMX-MDM2 complex as therapeutic target to restore p53 activity.

Entities:  

Keywords:  The MDM2/MDMX complex; oncogenic kinase; p53; signal hub

Year:  2016        PMID: 30319942      PMCID: PMC6178224          DOI: 10.21037/tcr.2016.12.18

Source DB:  PubMed          Journal:  Transl Cancer Res        ISSN: 2218-676X            Impact factor:   1.241


  60 in total

1.  RB regulates the stability and the apoptotic function of p53 via MDM2.

Authors:  J K Hsieh; F S Chan; D J O'Connor; S Mittnacht; S Zhong; X Lu
Journal:  Mol Cell       Date:  1999-02       Impact factor: 17.970

2.  Regulation of MDMX nuclear import and degradation by Chk2 and 14-3-3.

Authors:  Cynthia LeBron; Lihong Chen; Daniele M Gilkes; Jiandong Chen
Journal:  EMBO J       Date:  2006-03-02       Impact factor: 11.598

3.  Regulation of MDMX expression by mitogenic signaling.

Authors:  Daniele M Gilkes; Yu Pan; Domenico Coppola; Timothy Yeatman; Gary W Reuther; Jiandong Chen
Journal:  Mol Cell Biol       Date:  2008-01-02       Impact factor: 4.272

4.  MDMX: a novel p53-binding protein with some functional properties of MDM2.

Authors:  A Shvarts; W T Steegenga; N Riteco; T van Laar; P Dekker; M Bazuine; R C van Ham; W van der Houven van Oordt; G Hateboer; A J van der Eb; A G Jochemsen
Journal:  EMBO J       Date:  1996-10-01       Impact factor: 11.598

5.  The p53 inhibitors MDM2/MDMX complex is required for control of p53 activity in vivo.

Authors:  Lei Huang; Zheng Yan; Xiaodong Liao; Yuan Li; Jie Yang; Zhu-Gang Wang; Yong Zuo; Hidehiko Kawai; Miriam Shadfan; Suthakar Ganapathy; Zhi-Min Yuan
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-05       Impact factor: 11.205

6.  Secondary interaction between MDMX and p53 core domain inhibits p53 DNA binding.

Authors:  Xi Wei; Shaofang Wu; Tanjing Song; Lihong Chen; Ming Gao; Wade Borcherds; Gary W Daughdrill; Jiandong Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-25       Impact factor: 11.205

7.  Differential binding of p53 and nutlin to MDM2 and MDMX: computational studies.

Authors:  Thomas Leonard Joseph; Arumugam Madhumalar; Christopher J Brown; David P Lane; Chandra S Verma
Journal:  Cell Cycle       Date:  2010-03-15       Impact factor: 4.534

8.  Comparative study of the p53-mdm2 and p53-MDMX interfaces.

Authors:  V Böttger; A Böttger; C Garcia-Echeverria; Y F Ramos; A J van der Eb; A G Jochemsen; D P Lane
Journal:  Oncogene       Date:  1999-01-07       Impact factor: 9.867

9.  MDM4 is a key therapeutic target in cutaneous melanoma.

Authors:  Agnieszka Gembarska; Flavie Luciani; Clare Fedele; Elisabeth A Russell; Michael Dewaele; Stéphanie Villar; Aleksandra Zwolinska; Sue Haupt; Job de Lange; Dana Yip; James Goydos; Jody J Haigh; Ygal Haupt; Lionel Larue; Aart Jochemsen; Hubing Shi; Gatien Moriceau; Roger S Lo; Ghanem Ghanem; Mark Shackleton; Federico Bernal; Jean-Christophe Marine
Journal:  Nat Med       Date:  2012-07-22       Impact factor: 53.440

10.  Abnormal MDMX degradation in tumor cells due to ARF deficiency.

Authors:  X Li; D Gilkes; B Li; Q Cheng; D Pernazza; H Lawrence; N Lawrence; J Chen
Journal:  Oncogene       Date:  2011-11-28       Impact factor: 9.867

View more
  2 in total

1.  Understanding the interaction of 14-3-3 proteins with hDMX and hDM2: a structural and biophysical study.

Authors:  Sonja Srdanović; Madita Wolter; Chi H Trinh; Christian Ottmann; Stuart L Warriner; Andrew J Wilson
Journal:  FEBS J       Date:  2022-03-28       Impact factor: 5.622

2.  MDMX phosphorylation-dependent p53 downregulation contributes to an immunosuppressive tumor microenvironment.

Authors:  Bing Wang; Chuan-Bian Lim; Jiawei Yan; Lizhen Li; Jufang Wang; John B Little; Zhi-Min Yuan
Journal:  J Mol Cell Biol       Date:  2020-09-01       Impact factor: 6.216

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.